Cargando…
Dasatinib Inhibits CXCR4 Signaling in Chronic Lymphocytic Leukaemia Cells and Impairs Migration Towards CXCL12
Chemokines and their ligands play a critical role in enabling chronic lymphocytic leukaemia (CLL) cells access to protective microenvironmental niches within tissues, ultimately resulting in chemoresistance and relapse: disruption of these signaling pathways has become a novel therapeutic approach i...
Autores principales: | McCaig, Alison M., Cosimo, Emilio, Leach, Michael T., Michie, Alison M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487834/ https://www.ncbi.nlm.nih.gov/pubmed/23133664 http://dx.doi.org/10.1371/journal.pone.0048929 |
Ejemplares similares
-
Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro
por: Amrein, Lilian, et al.
Publicado: (2009) -
CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma
por: Werner, Thomas Artur, et al.
Publicado: (2018) -
Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia
por: Cui, Xue Yan, et al.
Publicado: (2021) -
CXCR7 Functions as a Scavenger for CXCL12 and CXCL11
por: Naumann, Ulrike, et al.
Publicado: (2010) -
CXCL12/SDF-1 and CXCR4
por: Nagasawa, Takashi
Publicado: (2015)